Menopause Rating Scale Questionnaire Research Articles

Effects of Flaxseed on Perimenopausal Symptoms: Findings From a Single-Blind, Randomized, Placebo-Controlled Study.

Background Flaxseed contains many phytoestrogens that share structural similarities with endogenous estrogens. It has beneficial properties that improve hormonal effects that may influence chronic disorders. Objective This study aims to evaluate the impact of flaxseed supplementation on perimenopausal syndrome symptoms and serum polyphenol metabolites enterodiol (ED) and enterolactone (EL). Methods Recruitment of 145 perimenopausal women from Queen Mary's Hospital OPD in K.G.M.U. Lucknow, India, was done for this single-blind randomized placebo-controlled experiment, considering inclusion and exclusion criteria. We randomly divided subjects into two groups using a computer-generated random number table. The intervention group A received 10 grams of flaxseed powder, while the placebo group B received 10 grams of roasted wheat flour for a continuous three months. We measured their demographic characteristics,menopausal symptoms score using the modified Kupperman's index (KI),the menopause rating scale (MRS), and the menopause-specific quality of life (MENQOL) intervention questionnaire. Moreover, using high-performance liquid chromatography (HPLC), biochemical parameters (ED, EL) were assessed both at baselineand after three months. For the statistical analysis, Statistical Product and Service Solutions (SPSS, version 24; IBM SPSS Statistics for Windows, Armonk, NY) was employed. Result The study involved 123 individuals, with 22 subjects losing out during follow-up. From baseline to follow-up comparison, the intervention group demonstrated an average percentage decline in the final score of the KI, MRS, and MENQOL intervention questionnaire of -47.25%, -54.05%, and -50.39%, respectively, while the placebo group demonstrated an average percentage decline of -3.83%, -4.91%, and -7.92%, respectively. From baseline to follow-up, ED and EL levels increased by 2.81-fold and 8.55-fold in the intervention group and decreased by 0.25-fold and 0.27-foldin the placebo group. Conclusion Following three months of supplementation, the intervention group showed substantially lower menopausal symptoms (p < 0.001), and ED and EL levels were considerably higher (p < 0.001). Therefore, flaxseed might ameliorate the symptoms associated with perimenopause.

Increase Menopause Symptoms of Women with Hormonal Contraceptive in Surakarta

During menopause, a woman will experience physical and psychological changes which often cause various complaints. There are several factors that are thought to be the cause of these complaints, such as education, use of hormonal contraceptives, and psycholog. The purpose of this study was to determine the severity of menopausal symptoms in terms of history of contraceptive use. This type of research is descriptive quantitative with cross sectional data collection using the Menopause Rating Scale questionnaire, with sampling techniques using non probability consecutive sampling techniques. inclusion criteria women aged 45 - 59 years and have stopped menstruating, have a history of using hormonal contraceptives, willing to be a respondent conducted in March 2024 until the number of respondents was obtained 30 people. Univariate analysis test with frequency distribution. The results showed that the severity of menopausal symptoms in women using contraceptives was none 3%, mild 33%, moderate 37%, and severe 27%. Conclusion of this study is the severity of menopausal symptoms in women who use hormonal contraceptives on average have moderate severity. The severity of menopausal symptoms is not only influenced by contraceptive use, but there are other factors such as education and psychological conditions.

THE INFLUENCE OF COUNSELING ON MENOPAUSE SYMPTOMS IN PONCOKUSUMO DISTRICT, MALANG REGENCY, 2022

Introduction: Eighty percent (80%) of women complaint headache, sexual problem, tachycardia, hot flushes and insomnia, that are significantly decrease the quality of life.&#x0D; Method: Objective of the research is to analyze how much the effect of menopause counseling from counselor midwife towards reduction of the symptoms menopause. The study is quasi experiment with pre and post design. The samples were 40 respondents that were divided into two groups. In each group counseling was given twice at intervals of 2 weeks, long counseling per client requirements. The instruments employed were MRS (Menopause Rating Scale) questionnaire. Non parametric and RR value were performed for statistical test.&#x0D; Results: The result of study indicated that the While menopause mothers who did not receive counseling by a midwife counselor, 2.5 times the risk of having symptoms degree rise or stay when compared with mothers who received counseling by a midwife counselor (RR 2.5).&#x0D; Conclusion: Based on the study, it was concluded that there was effect of counseling from counselor midwife towards the decrease of menopausal symptoms.

Menopausal Symptoms and Menopausal Rating Scale among Midlife Women: A Hospital-based Study.

Menopausal transition phase is a difficult time in a woman's life. Many factors such as age, socioeconomic status, education, ethnic cultural, and body physique determine the presence of menopausal symptoms. This study helps us to understand the severity and perseverance of menopausal symptoms in women of this locality. The aim of the study was to find distribution and severity of menopausal symptoms by self-rated Menopause Rating Scale (MRS) through different transition phases of menopause in women aged between 40 and 60 years. It is a hospital-based observational study. All the participants answered an 11-item MRS questionnaire. Out of 300 participants, 106 belonged to premenopausal state, 111 to perimenopausal state, and 83 were postmenopause. Overall, 47% of participants had one or the other menopausal symptoms. Most of them had mild-to-moderate symptoms. Only 3% had severe symptoms. Somatic subscale was the maximum reported symptoms in our study group. The most common symptom was physical and mental exhaustion (55%) and the least common was sexual problems (8%). Difficulty in sleeping and bladder symptoms were more and statistically significant in postmenopausal group where as hot flushes and irritability were more common in perimenopausal group. Somatic subscale symptoms are more common than urogenital or psychosocial subscales. Postmenopause women manifested higher symptoms than premenopause or perimenopause group women and most were mild to moderate in severity in women visiting our hospital.

Effect of Fennel Aromatherapy (Foeniculum Vulgare) On Decreasing Menopause Symptom Levels in Menopausal Women in Tunjung Village Bangkalan Regency Indonesia

Menopause is a natural event in a woman's life cycle. Hormonal changes that occur during menopause cause more than 80% of women to experience symptoms both physical and psychological with various pressures and disorders, causing a decrease in the quality of life. One of the non-pharmacological treatments to reduce the level of menopausal symptoms is Fennel aromatherapy. This study aims to determine the effect of Fennel Aromatherapy on reducing the level of menopausal symptoms. This type of research is Quasy Experimental with Non-Equivalent Control Group Design. The population of postmenopausal women aged 45-55 years is 62 people. Samples were taken using the purposive sampling technique of 22 people per group. The instrument used is the MRS (Menopause Rating Scale) questionnaire. statistical test using Wilcoxon Matched Pairs Test with α 0.05. The results showed that most menopausal women (68.2%) from the control group and most menopausal women (72.7%) from the treatment group had severe menopausal symptoms. After being given the intervention, there was a decrease in the treatment group where half of menopausal women (50.0%) had moderate levels of menopausal symptoms. The results of the analysis obtained p-value 0.000058 or &lt;α (0.05) which means that there is an influence of Fennel Aromatherapy (Foeniculum Vulgare) on decreasing the level of menopausal symptoms. This research can add alternative treatment for menopausal symptoms in the BATRA program at community health centers. It is hoped that postmenopausal women can use safe alternative therapies such as Fennel Aromatherapy to treat menopausal symptoms so that it can improve the quality of life of women during menopause without serious side effects.

Efektivitas Suplementasi Semanggi Merah Dan Minyak Ikan Terhadap Kualitas Hidup Wanita Pascamenopause

Menopause causes major changes in reproductive and non-reproductive tissues. Estimating that 75% of postmenopausal women experience severe complaints. Changes during the menopausal transition risk-reducing women's quality of life. Supplementation of red clover and fish oil are some supplements that are used to overcome various menopause complaints. There are still few studies that compare the effectiveness of the two to improve quality of life. This study was to compare red clover with fish oil supplementation to improve the QOL in postmenopausal women. The quasi-experimental study with a nonequivalent control group design of 60 postmenopausal women was conducted. Participants were selected by consecutive sampling and equally divided into two groups. Each group was given red clover 400 mg once a day and fish oil supplementation 1000 mg (contains omega-3 marine triglycerides 300 mg as Eicosapentaenoic Acid (EPA) 180 mg and Docosahexaenoic Acid (DHA) 120 mg) once a day for twelve weeks. Quality of life was assessed using WHOQOL-BREF and postmenopausal complaints using a menopause rating scale questionnaire. The data were analyzed by Mann-Whitney U test, Wilcoxon Signed Rank test, and paired sample t-test. The mean (standard deviation) scores of the menopause rating scale (MRS) in the fish oil group were lower (2.10 [3.30]) than in the red clover group (3.97 [5.15]); p = 0.100. There were differences in QOL scores in the domain of psychical health (p=0.006), psychological (0.005), social relationships (0.010), and environment (0.010) in the fish oil group. In contrast, in the red clover group, differences were found in the domain of psychological (p=0.020), social relationships (0.022), and environment (0.002). There was no difference between the two groups.Fish oil supplementation was as effective as red clover to improve quality of life. Fish oil and red clover supplementation should be given to postmenopausal women with menopause complaints.

The Effect of Menopause Counseling by Counselor Midwives on Attitude and Reduction of Menopause Symptoms in Menopausal Mothers

Eighty percent (80%) of women complaint headache, sexual problem, tachycardia, hot flushes and insomnia, that are significantly decrease the quality of life. Objective of the research is to analyze how much the effect of menopause counseling from counselor midwife towards the attitude of menopause women and reduction of the symptoms. The study is quasi experiment with pre and post design. The samples were 40 respondents that were divided into two groups; 20 respondents were in intervention group who were given counseling from counselor midwife and 20 respondents were in control group that were given counseling from non counselor midwife. In each group counseling was given twice at intervals of 2 weeks, long counseling per client requirements. Measurement posttest mother's attitude menopause and the symptoms of menopause mother performed 4 weeks after the pretest. The instruments employed were MAMES (Multi-dimensional Attitudes Menopause Scale) questionnaire for measuring the attitude of menopause women and MRS (Menopause Rating Scale) questionnaire for measuring the symptoms experienced by menopause women. Non parametric and RR value were performed for statistical test. The result of study indicated that the attitude, the mother menopause who did not receive counseling by a midwife counselor, the risk of having a negative attitude 7 times compared with mothers who received counseling by a midwife counselor (RR 7.0). While menopause mothers who did not receive counseling by a midwife counselor, 2.5 times the risk of having symptoms degree rise or stay when compared with mothers who received counseling by a midwife counselor (RR 2.5). Based on the study, it was concluded that there was effect of counseling from counselor midwife towards the improvement of attitude of menopause women and decrease of menopausal symptoms.

The Impact of Soy Isoflavone Supplementation on the Menopausal Symptoms in Perimenopausal and Postmenopausal Women.

Introduction:Approximately one-third of a woman's life is spent in the menopausal phase. The unpleasant menopausal symptoms are unacceptable as a part of routine life. Indications of menopausal hormone therapy (MHT) are for alleviation of vasomotor symptoms, prevention of osteoporosis, and genitourinary symptoms associated with menopause. MHT is associated with an increased risk of breast cancer, cerebrovascular accidents, and coronary heart disease. Soy isoflavones have been extensively used as an alternative treatment in patients who cannot take MHT. The evidence of the efficacy of isoflavones in the literature is equivocal.Aim:The aim of the study was to evaluate the efficacy of soy isoflavone supplementation on menopausal symptoms in perimenopausal and postmenopausal women and to evaluate the effect on blood pressure (BP) and body mass index (BMI).Materials and Methods:A questionnaire-based prospective observational study was undertaken involving 39 perimenopausal and 61 postmenopausal women, who were prescribed 40 mg soy isoflavone supplements twice daily for 12 weeks. Menopause Rating Scale questionnaire was given to the patients before starting soy isoflavone therapy and at the end of the treatment; BP and BMI were also noted.Results:The total score of both the groups was comparable at baseline. Among perimenopausal and postmenopausal women, the highest score was noted in symptoms of somatic domain. At the completion of our study, the total scores improved significantly by 38.6% and 33.3% in perimenopausal and postmenopausal women, respectively. The greatest improvement was seen in somatic subscale (42.5%) and psychological subscale (42.5%) and the least in urogenital subscale (16.1%) for perimenopausal women. For postmenopausal women, the greatest improvement was seen in psychological subscale (40.0%) and the least in urogenital subscale (14.2%).Conclusion:Soy isoflavone supplementation is beneficial in both perimenopausal and postmenopausal women, more so in perimenopausal women. There is no beneficial effect of soy isoflavone supplementation on lowering systolic BP and BMI.

Cimicifuga racemosa isopropanolic extract for menopausal symptoms: an observational prospective case–control study

Objective We aimed to investigate the effectiveness of isopropanolic extract of Cimicifuga Racemosa (iCR) on reducing menopausal symptoms. Materials and Methods A single-center observational prospective case–control study was performed to assess the improvement of menopausal symptoms in menopausal women undergone iCR administration (cases) or no treatment (controls). Menopausal symptoms were assessed through a modified version of the Menopause Rating Scale questionnaire (mMRS) at T0 (baseline), T1 (1-month follow-up), and T2 (3 months follow-up). Univariate comparisons between cases and controls were performed by using the unpaired T test for two-tailed P value with α = 0.05 significance level. Results A total of 163 women (83 cases and 80 controls) were enrolled in the study. The difference in menopausal symptoms between cases and controls from T0 to T2, and from T0 to T1, was found significant for all analyses. In particular, the difference in all menopausal symptoms was 20.56 ± 0.90 points (95%CI: 18.77–22.33, p < .001) from T0 to T2, and 10.69 ± 0.6 (95%CI: 9.49–11.88, p < .001) from T0 to T1. Conclusion iCR may be effective in reducing menopausal symptoms, both after 1 month and after 3 months of treatment. The improvement was higher in vasomotor symptoms, sleep problems, and irritability.

Fatores associados à qualidade de vida em mulheres idosas pós-menopausa

O climatério é uma fase da vida da mulher que se caracteriza pelo final da vida reprodutiva e o início da senescência. O objetivo deste estudo foi avaliar como as alterações físicas e fisiológicas da menopausa influenciam a qualidade de vida das mulheres, para tanto, foi utilizado o questionário Menopause Rating Scale. A amostra foi composta por 100 mulheres, com média de idade de 67,2 (±8,3) anos. O início da menopausa foi aos 48,06 anos (±8,06). No Menopause Rating Scale, houve presença de sintomatologia em 91% das participantes, a intensidade frequente foi a moderada, em cada um dos domínios, os sintomas dominantes foram as queixas locomotoras, o esgotamento físico e mental e a secura vaginal. Na correlação entre as queixas e comorbidades, o resultado foi significativo (p=0.05). Conclui-se que os sintomas apresentados na pós-menopausa não influenciam diretamente a qualidade de vida dessas mulheres.&#x0D;

Dietary inflammatory index and dietary energy density are associated with menopausal symptoms in postmenopausal women: a cross-sectional study.

No previous study has evaluated the association of the dietary inflammatory index (DII) and dietary energy density (DED) with menopausal symptoms and its subclasses in postmenopausal women. The aim of this study was to evaluate the association of DII score and DED with menopausal symptoms and its subtypes in Iranian postmenopausal women. This cross-sectional study was conducted on 393 postmenopausal women who attended health centers in the south of Tehran, Iran. The DII score was calculated using dietary factors obtained by a validated food frequency questionnaire. DED was defined as average daily energy intake (kcal) per gram of food. The Menopause Rating Scale questionnaire was used to evaluate the menopausal symptoms. The total Menopause Rating Scale score (TMRSS) was the sum of the somatic score (SS), psychological score (PS), and urogenital score. Linear regression analysis was used to assess the association of the DII score and DED with menopausal symptoms. After adjusting for covariates, participants in the highest tertile of DII score had greater SS compared to those in the lowest tertile (βDIIt3vs1= 0.032, 95% confidence interval (CI): 0.004-0.068, P = 0.04). No significant relationship was found between DII score and PS, urogenital score or TMRSS. Furthermore, higher DED was associated with greater SS (βDIIt3vs1 = 0.071, 95% CI: 0.028-0.115, P = 0.001), PS (βDIIt3vs1 = 0.065, 95% CI: 0.012-0.121, P = 0.01) and TMRSS (βDIIt3vs1 = 0.053, 95% CI: 0.017-0.088, P = 0.004). A proinflammatory diet was associated with higher menopause-specific somatic symptoms and higher DED was positively associated with menopausal symptoms.

Association between physical activity, cardiorespiratory fitness, and body composition with menopausal symptoms in early postmenopausal women.

The aim of this study was to investigate the relationship between daily physical activity (daily activities, exercise, and sitting time), cardiorespiratory fitness (CRF), and body composition (body mass index [BMI], waist to hip ratio [WHR)] with menopausal symptoms and to determine the strongest predictor(s) of menopausal symptoms. The Menopause Rating Scale questionnaire was used to examine somatic, psychological, urogenital, and total symptoms of menopause. The energy expenditure of daily physical activity, exercise, and sitting time was measured by the International Physical Activity Questionnaire, and CRF was measured by estimating the maximal oxygen intake (VO2max) through the Rockport test. Statistical methods of the Pearson correlation coefficient and hierarchical multiple linear regression were used for data analysis. Fifty-six women, aged 50 to 65 years, voluntarily participated in the study. Exercise energy expenditure was inversely correlated with total (r = -0.403, P = 0.002), somatic (r = -0.293, P = 0.023), and urogenital (r = -0.343, P = 0.009) symptoms of menopause. VO2max was inversely correlated with urogenital symptoms of menopause (r = -0.414, P = 0.002). WHR was positively correlated with somatic symptoms of menopause (r = 0.286, P = 0.032); sitting was correlated with total (r = 0.40, P = 0.002), somatic (r = 0.325, P = 0.015), and psychological (r = 0.274, P = 0.015) symptoms of menopause. Among the study variables, sitting (β=0.365, P = 0.004) and VO2max (β=-0.286, P = 0.030) were the most important predictors of total symptoms of menopause; sitting was the predictor of somatic symptoms (β=0.265, P = 0.045), and VO2max was the predictor of urogenital symptoms of menopause (β=-0.332, P = 0.014). The inclusion of age, BMI, WHR, and duration of menopause as confounding variables in regression analysis did not change the findings related to the predictions of menopausal symptoms. Reducing sitting time, improving VO2max, decreasing WHR, and exercise can be recommended by priority to alleviate menopausal symptoms. Considering the small number of participants in this investigation, future studies are, however, recommended.

Improving menopausal symptoms and reducing depression in postmenopausal women: Effectiveness of transferring experiences in group education.

INTRODUCTION:One of the most critical stages of women's lives is menopause. Meanwhile, group training can have a significant effect on reducing menopausal symptoms. The aim of this study was to investigate the effectiveness of group training on reducing menopausal symptoms in postmenopausal women.METHODS:This study was a randomized controlled trial. The study population was 96 postmenopausal women visiting health centers in the city of Shazand (Markazi Province, Iran). Data collection tools in this study were the Menopausal Rating Scale Questionnaire and the Beck Depression Inventory. Group training intervention consisted of four training sessions. The duration of each session was 2 h. The questionnaires were completed in two stages of pre- and post-test (8 weeks later) for the intervention and control groups. Data were analyzed using descriptive statistics (absolute and relative frequency, mean and standard deviation) and analytical statistics (independent t-test, paired t-test, and analysis of covariance).RESULTS:The mean age in the intervention group and the control group was 49.93 ± 3.44 and 51.66 ± 2.93 years, respectively. In the intervention group, the mean menstrual time was 2.37 ± 167 years and in the control group, the mean time elapsed from the last menstrual period was 3.91 ± 2.68 years. The mean scores of menopausal physical symptoms (F = 58.69), menopausal symptoms (F = 43.45), menopausal urinary and genital symptoms (F = 33.50), and depression (F = 58.25) had a significant decrease in intervention group, while in the control group, these changes were not significant (P < 0.001).CONCLUSION:Regarding the findings of this study, which indicates the effect of group training program on the improvement of physical, psychological, urinary and genital symptoms, and menopausal depression, it seems that group training in menopause can be an effective method.

The relationship of menopausal symptoms with the type of menopause and lipid levels.

IntroductionMany postmenopausal women experience hot flashes, night sweats, decreased sexual desire and vaginal dryness. In this study, we aimed to compare the menopause symptom levels of surgical menopause patients and natural menopause patients by using a Menopause Rating Scale (MRS) and investigate whether there is a relationship between lipid levels and menopausal symptoms in surgical menopause patients.Material and methodsThis cross-sectional study was conducted on postmenopausal women who applied to the gynecology outpatient clinic. A total of 187 patients were analyzed. Of these,112 were the surgical menopause group and the remaining 75 were the natural menopause group. Total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol and triglycerides were measured by using an enzymatic color test. In order to evaluate the postmenopausal symptoms of postmenopausal women included in the study, the MRS questionnaire adapted to the Turkish population was used.ResultsConsidering the results of the MRS of the two groups, the results of surgical menopause patients were found to be statistically significantly higher. The results were statistically significantly higher in both the total score and in the two subgroups(somatic and psychological subgroups)in the surgical menopause group. When the MRS results(subgroups and total score)of women in the surgical menopause group were classified as mild and severe, no statistically significant relationship was found between symptom severity and blood lipid levels.ConclusionsIn the surgically induced menopause group, it was shown by this study that menopausal symptoms were more severe than the natural menopause group. Unlike natural menopausal patients, no relationship was found between lipid levels and severity of menopausal symptoms in surgical menopausal patients.

Comparison of the Efficacy of Tibolone and Transdermal Estrogen in Treating Menopausal Symptoms in Postmenopausal Women.

ObjectivesThis study aimed to compare the efficacy of tibolone and transdermal estrogen in treating menopausal symptoms in postmenopausal women with an intact uterus.MethodsOverall, 26 women consumed tibolone orally and 31 women received transdermal estrogen gel mixed with progestogen. The menopause rating scale (MRS) was used to assess their menopausal symptoms at their first outpatient visit and 6 months later.ResultsThe transdermal estrogen group showed significant improvements in more items of the MRS questionnaire. There was a favorable change in body weight in the transdermal estrogen group compared with that in the tibolone group. Depressive mood, irritability, physical and mental exhaustion, sexual and bladder problems, and joint and muscular discomfort improved only in the transdermal estrogen group, whereas heart discomfort and vaginal dryness improved only in the tibolone group. Nevertheless, the intergroup differences in each item were insignificant after adjusting for body mass index and hypertension, which differed before treatment.ConclusionsBoth the therapeutic options improved menopausal symptoms within 6 months of use. However, transdermal estrogen appeared to be more effective in preventing weight gain in menopausal women than tibolone.

Effect of Foeniculum vulgare Mill. (fennel) on menopausal symptoms in postmenopausal women: a randomized, triple-blind, placebo-controlled trial.

Preliminary data suggest that Foeniculum vulgare (fennel) can be an effective treatment for menopausal symptoms. This trial was designed to assess the efficacy of fennel in the management of menopausal symptoms in postmenopausal women. In this triple-blind, placebo-controlled trial, 90 postmenopausal women aged 45 to 60 years in Tehran were randomly assigned to treatment (n = 45) or placebo (n = 45) groups. The participants received 8 weeks of treatment with soft capsules containing 100 mg fennel or a placebo (2 per day for each group). The participants were followed for 2 weeks postintervention to assess the continuance of the effect of intervention. The Menopause Rating Scale (MRS) questionnaire was used to assess changes in menopausal symptoms at baseline and at 4, 8, and 10 weeks after onset of intervention. The groups recorded similar mean scores on the MRS questionnaire before intervention. After intervention, the treatment group showed a significant decrease in the mean MRS score. The results of the Friedman test showed significant differences between the mean score at baseline and those at 4, 8, and 10 weeks after onset of intervention in the treatment group (P < 0.001), whereas there were no significant differences in the placebo group. When the fennel and the placebo groups were compared, the independent t test showed significant differences in mean scores between groups at 4, 8, and 10 weeks (2 weeks postintervention; P < 0.001). Fennel is an effective and safe treatment to reduce menopausal symptoms in postmenopausal women without serious side effects. More clinical trials with larger populations are required to confirm this result.

Does obesity increase the risk of hot flashes among midlife women?: a population-based study.

To evaluate the association between vasomotor symptoms and obesity in climacteric women. We conducted a cross-sectional population-based study of 749 women aged 45 to 60 years. The dependent variable was intensity of menopausal symptoms evaluated by the menopause rating scale questionnaire. Independent variables were sociodemographic and clinical characteristics, and obesity evaluated by body mass index. There was no significant difference in the majority of clinical and sociodemographic characteristics between the body mass index groups. Obese women had less physical activity (P = 0.019) and a higher prevalence of hypertension (P < 0.001), diabetes (P = 0.002), urinary incontinence (P < 0.001), and urge incontinence (P = 0.0006). The total mean menopause rating scale score was 9.7. Scores for hot flashes increased progressively and were higher for participants with body mass index greater than 30 kg/m (P = 0.027). Joint and muscle pain scores also increased with increased body mass index (P < 0.001). Regarding urogenital symptoms, there was a significant difference in urinary problems only, which were more intense in obese women (body mass index >30 kg/m) (P < 0.0001). There was no significant difference in any psychological symptoms on the menopause rating scale. Factors associated with hot flash scores were higher body mass index, presence of urinary urgency, and vaginal dryness. We found that menopausal symptoms, including vasomotor, joint, and urinary symptoms, were related to obesity. Hot flashes were associated with higher body mass index, urinary urgency, and vaginal dryness. Understanding this relationship may contribute to the development of healthcare strategies aimed at minimizing the impact of obesity on several health issues of climacteric women.

Utilizing the Menopause Rating Scale questionnaire in electronic form for evaluating the quality of life in postmenopausal women

The objective of the research study was to assess the possible use of a Czech standardized version of the Menopause Rating Scale questionnaire in electronic form, concerning the quality of women's life in the period affected by menopause.The quantitative survey was conducted in 2015 on a sample of 364 respondents within the age range from 45 to 60 years with present oestrogen deficiency symptoms. The respondents filled in the Menopause Rating Scale questionnaire in their own social environment using an online form based on previous education. The data was then subjected to statistical evaluation; results were compared with the results of data collected in the form of a printed questionnaire.Most frequently, the respondents reported a minor intensity of difficulties or absence of some symptoms. The respondents encountered the least distinctive difficulties in the urogenital domain. Based on the resulting values of the total score in the partial domains, we can state that the quality of women's life was only affected by the present oestrogen deficiency to a minor extent. The results correspond with those of researches utilizing the form of a printed questionnaire.One of the tasks of the clinical practice and preventive measures in the area of gynaecology and obstetrics is to prepare women to changes related to menopause and to provide them with adequate information. Medical staff must have such an evaluation instrument available that can be used for evaluating potential changes in this period and then help the women adequately. The Menopause Rating Scale is such a tool. The electronic form of this instrument appears to be a suitable form for initiating communication between the client and medical staff. At the same time it allows the woman to obtain initial and immediate feedback concerning her perceived problems.

Current scenario of menopause-related symptoms using menopause rating scale among middle-aged women of Western India: A cross-sectional study

Background: Even though menopause is a natural phenomenon, it causes symptoms ranging from vasomotor symptoms to sleep disturbance, mood disorders, loss of sexual desire, and vaginal dryness. During the menopausal transition, women may experience a variety of symptoms. Many a time women are unaware of these symptoms and they do not seek treatment for the same. Objective: (1) To assess menopausal-related symptoms among middle-aged women using menopause rating scale (MRS) and (2) to assess the severity of symptoms according to the menopausal status of women. Materials and Methods: The cross-sectional study was conducted among 425 middle-aged women residing in field practice areas of Urban Health Training Center of present teaching hospital. The menopausal status is classified according to STRAW + 10 classifications. The English version of the MRS questionnaire was used as a tool for assessing menopausal symptoms. Results: Of 425 women evaluated, the mean age of attaining menopause was 42.8 years. Menopause-related symptoms were present among 304 (71.5%) women. Majority of women suffered joint and muscular discomfort (62.6%), 47.5% had hot flushes, and physical as well as mental exhaustion. Logistic regression analysis reveals that postmenopausal women had highest prevalence of menopausal symptoms as compared to other groups. Conclusion: Age of attaining menopause was bit lower in present study. Availability of treatment modalities for various menopause-related symptoms requires women’s attention to improve their quality of life.

Relationship between sociodemographic, reproductive, and lifestyle factors and the severity of menopausal symptoms among Egyptian women in Alexandria.

During menopause, women often experience some symptoms which may affect their daily activities. Information about menopausal experiences among different racial and ethnic groups is important for healthcare personnel to provide appropriate and specific interventions. The aim of the present study was thus to determine the frequency and determinants of severity of menopausal symptoms among Egyptian women using the Menopause Rating Scale as a screening tool for identification of menopausal symptoms. A total of 540 women (aged 40-65 y) were recruited in this cross-sectional study. Demographic information was collected, and the Menopause Rating Scale questionnaire was administered. Most frequently reported symptoms were joint and muscular discomfort (501, 92.8%) followed by urogenital symptoms (460, 85.2%). A significant association was found between the number of menopausal symptoms and working status of participants (r = 0.504, P = 0.005), number of children (r = 0.474, P = 0.042), and body mass index (r = 0.544, P = 0.006). Women who reported urogenital symptoms and self-perceived general health as poor were more frequently referred to a gynecologist for moderate-to-severe menopausal symptoms. Participant-related information such as working status, which was shown to increase the frequency of psychological symptoms in our ethnic group, should be noted by the physician, and a suitable approach should be adopted to achieve better therapy outcomes. Counseling about the importance of maintaining an ideal body weight and exercise should be emphasized to reduce menopausal symptoms. Appropriate advice and support in improving the overall state of the postmenopausal women is essential.